The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly
heterogeneous patient population and therefore poses unique challenges for therapeutic …

Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an
increasing incidence. With advances in surgical techniques and instrumentation and the …

Automatic segmentation of abdominal organs in CT scans plays an important role in clinical
practice. However, most existing benchmarks and datasets only focus on segmentation …

Background Hepatocellular carcinoma (HCC) is one of the most common and devastating
malignancies. Oxaliplatin, a platinum-based chemotherapeutic agent, is approved for the …

Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in
adults and the third most common cause of cancer death worldwide. The incidence of HCC …

The incidence of hepatocellular carcinoma (HCC) is expected to increase in the next 2
decades, largely due to hepatitis C infection and secondary cirrhosis. HCC is being detected …

Hepatocellular carcinoma (HCC) constitutes most primary liver cancers and is one of the
most lethal and life-threatening malignancies globally. Unfortunately, a substantial …

Microvessel invasion is a major prognostic factor in hepatocellular carcinoma (HCC) that
influences the suitability of surgery, but rarely can be evaluated preoperatively. This study …

Purpose To retrospectively assess the local control and intermediate-and long-term survival
of patients with liver metastases from breast cancer who have undergone percutaneous …

The purpose of this study is to report on the feasibility, local response, and 1-year clinical
outcome of bland transarterial embolization (TAE) with 40-and 100-μm Embozene …